Insulin glargine and lixisenatide Subcutaneous and Quinupristin and dalfopristin Intravenous
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Quinupristin and dalfopristin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: dalfopristin / quinupristin
Brand name: Synercid
Synonyms: Dalfopristin and quinupristin, Quinupristin and Dalfopristin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-QuinZyme coenzyme Q-10
- Insulin glargine and lixisenatide Subcutaneous-Quiphile
- Insulin glargine and lixisenatide Subcutaneous-Quit Nicotine Gum - Mint
- Insulin glargine and lixisenatide Subcutaneous-Qutenza
- Insulin glargine and lixisenatide Subcutaneous-Qvar
- Insulin glargine and lixisenatide Subcutaneous-Qvar Redihaler
- Quinupristin and dalfopristin Intravenous-Insulin glargine, recombinant Subcutaneous
- Quinupristin and dalfopristin Intravenous-Insulin glulisine
- Quinupristin and dalfopristin Intravenous-Insulin Glulisine (Cartridges and Pens)
- Quinupristin and dalfopristin Intravenous-Insulin Glulisine (Vials)
- Quinupristin and dalfopristin Intravenous-Insulin glulisine Subcutaneous
- Quinupristin and dalfopristin Intravenous-Insulin human inhaled Inhalation